Dr. Lal PathLabs Limited

BSE:539524 Stock Report

Market Cap: ₹245.5b

Dr. Lal PathLabs Past Earnings Performance

Past criteria checks 5/6

Dr. Lal PathLabs has been growing earnings at an average annual rate of 8.1%, while the Healthcare industry saw earnings growing at 22.7% annually. Revenues have been growing at an average rate of 11.9% per year. Dr. Lal PathLabs's return on equity is 20%, and it has net margins of 17.1%.

Key information

8.1%

Earnings growth rate

7.9%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate11.9%
Return on equity20.0%
Net Margin17.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dr. Lal PathLabs makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:539524 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2423,4644,0144,3120
30 Jun 2422,8753,8154,2270
31 Mar 2422,2663,5774,1350
31 Dec 2321,7223,2983,8560
30 Sep 2321,2273,0133,7720
30 Jun 2320,5522,6382,8690
31 Mar 2320,1692,3883,5770
31 Dec 2220,1142,4353,3490
30 Sep 2220,1892,4803,2990
30 Jun 2219,8352,7133,2550
31 Mar 2220,8743,4483,4800
31 Dec 2120,3293,6693,3030
30 Sep 2119,8844,0413,2640
30 Jun 2119,2193,9443,1260
31 Mar 2115,8132,9162,5010
31 Dec 2014,5202,4072,3430
30 Sep 2013,2752,0032,1600
30 Jun 2012,6121,9552,0790
31 Mar 2013,3042,2592,2220
31 Dec 1913,2982,4052,5400
30 Sep 1912,9442,3222,4930
30 Jun 1912,4632,0862,4120
31 Mar 1912,0341,9922,3410
31 Dec 1811,6911,9232,2940
30 Sep 1811,3931,8252,2380
30 Jun 1810,9991,7612,1730
31 Mar 1810,5691,7072,1020
31 Dec 1710,1001,6178980
30 Sep 179,5481,5658080
30 Jun 179,3891,5867520
31 Mar 179,1241,5461,6940
31 Dec 168,9021,5767000
30 Sep 168,7131,8766760
30 Jun 168,2491,4136250
31 Mar 167,9131,3225800
31 Dec 157,6541,2012,15211
31 Mar 156,5969084970
31 Mar 145,5797631,75510

Quality Earnings: 539524 has high quality earnings.

Growing Profit Margin: 539524's current net profit margins (17.1%) are higher than last year (14.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 539524's earnings have grown by 8.1% per year over the past 5 years.

Accelerating Growth: 539524's earnings growth over the past year (33.2%) exceeds its 5-year average (8.1% per year).

Earnings vs Industry: 539524 earnings growth over the past year (33.2%) exceeded the Healthcare industry 29.6%.

Return on Equity

High ROE: 539524's Return on Equity (20%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 00:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Lal PathLabs Limited is covered by 44 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
null nullAntique Stockbroking Ltd.
Harith AhamedAvendus Spark